Merrimack Pharmaceuticals (MACK) null Earnings

4NovConfirmed
Mar 21
May 21
Aug 21
Nov 21
-0.67
-0.34
-0
0.33

Details

Expected EPS
N/A
Actual EPS
-0.67
Surprise EPS
-0.67
Surprise Percent
+∞%

Description

Merrimack Pharmaceuticals (MACK) has reported earnings of -0.67 per share for .

0 Comments

Share your thoughts